Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
The study evaluated physical and mental health parameters, including cognitive/functional effects and depression, in older adults with newly…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant [Phase 2]
Phase 2 trial of azacitidine in patients with relapsed myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [NA]
Clinical trial update reports results of a conditioning regimen using fludarabine and total-body irradiation followed by donor stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
Clinical trial update describing biomarker analyses in blood samples from patients with acute myeloid leukemia; the study is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
Phase 2 trial evaluating haploidentical donor bone marrow transplantation in patients with high-risk hematologic cancers; results completed …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
This is a completed clinical trial update focusing on biomarkers in bone marrow from patients with acute myeloid leukemia. The study is spon…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy
Biomarker study analyzing bone marrow and blood samples from older adults with acute myeloid leukemia treated with cytarabine-based therapy;…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Transfusional Iron Overload Among Leukemia Survivors
A completed study examining the occurrence and implications of transfusional iron overload in survivors of acute lymphoblastic leukemia and …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease [Phase 2]
Phase 2 study of the combination of clofarabine and cytarabine in adults with acute myeloid leukemia across various cytogenetic subtypes and…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML [Phase 3]
Phase 3 trial evaluating vosaroxin with cytarabine vs placebo with cytarabine in patients with first relapsed or refractory acute myeloid le…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission [Phase 2]
A Phase 2 trial evaluating conditioning with fludarabine and busulfan followed by allogeneic stem cell transplantation in older adults with …
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial assessing the combination of lithium carbonate and tretinoin in adults with relapsed or refractory acute myeloid leukemia has …
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial [NA]
This entry notes a completed randomized trial comparing Dual Energy CT to Standard Triple Phase CT Angiography. The study involved patients …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia [Phase 1, Phase 2]
This document reports an update on a Phase 1/2 clinical trial evaluating treatment for relapsed or refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
This document reports on a Phase 3 trial evaluating all-trans retinoic acid added to standard induction and consolidation therapy in older p…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating MS-275 (entinostat) in combination with GM-CSF in adults with myelodysplastic syndromes and/or relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay [NA]
Clinical trial update on using a high-throughput drug sensitivity assay to guide treatment for relapsed/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
This clinical trial update reports results from a completed study evaluating saline-washed platelet and red cell transfusions in adults with…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.